Inogen, Inc - Common Stock (INGN)
8.3700
-0.1400 (-1.65%)
NASDAQ · Last Trade: Oct 17th, 10:59 PM EDT
Via Benzinga · June 10, 2025
Needham's Mike Matson upgrades Inogen to Buy, citing turnaround progress, margin gains, and path to EBITDA breakeven by 2025.
Via Benzinga · May 22, 2025
Via Benzinga · May 22, 2025

Inogen beat Q4 earnings and revenue estimates, citing strong B2B demand. Analysts see potential but flag supply challenges and restructuring risks.
Via Benzinga · February 26, 2025

Inogen reported Q4 2023 revenues of $75.9 million, missing consensus. Despite challenges, the company's improvements position it well.
Via Benzinga · February 28, 2024

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.
Via Benzinga · February 27, 2024

Pre-market stock movers are a hot topic on Wednesday and we have all of the latest news traders need to know about them this morning!
Via InvestorPlace · August 7, 2024

Discover the growth potential of top small-cap stocks in the consumer finance, healthcare equipment and pharmaceutical industries.
Via InvestorPlace · July 22, 2024

INGN stock results show that Inogen beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 7, 2024

Via Benzinga · May 7, 2024

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling around 100 points on Wednesday. The Dow traded down 0.27% to 38,867.91 while the NASDAQ fell 0.50% to 15,954.75. The S&P 500 also fell, dropping, 0.18% to 5,068.92.
Via Benzinga · February 28, 2024

Shares of Bumble Inc. (NASDAQ: BMBL) fell sharply during Wednesday’s session following weak quarterly results.
Via Benzinga · February 28, 2024

Via Benzinga · February 28, 2024

U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 50 points on Wednesday. The Dow traded down 0.19% to 38,899.92 while the NASDAQ fell 0.31% to 15,985.25. The S&P 500 also fell, dropping, 0.11% to 5,072.67.
Via Benzinga · February 28, 2024

Via Benzinga · February 28, 2024

Via Benzinga · February 27, 2024

Impact of Philips' decision to halt CPAP device sales in the U.S. and its potential market implications. William Blair sees a significant opportunity for Inogen to reclaim market share.
Via Benzinga · February 15, 2024

Via Benzinga · February 15, 2024

Inogen, Inc (NASDAQ: INGN) shares are trading higher on Wednesday. Earlier in the day, Citron Research posted a tweet about the company on its X account.
Via Benzinga · January 31, 2024

Shares of Methode Electronics, Inc (NYSE: MEI) fell sharply during Thursday’s session following weak quarterly earnings.
Via Benzinga · December 7, 2023